The outlook for people diagnosed with early-stage pancreatic cancer can be expected to improve due to the results from two clinical trials. In the first trial, changing the type of chemotherapy given after surgery from a single drug to a multi-drug regimen greatly improved how long patients lived. Patients in the trial treated with the multi-drug regimen survived for an average of 4.5 years after treatment, substantially longer than expected.
To read more about the clinical trials, click here.
We are really grateful for your blog post. You will find a lot of approaches after visiting your post. I was exactly searching for. Thanks for such post and please keep it up. Great work. Pancreatic cancer
ReplyDelete